Ragon Institute of Mass General, MIT, and Harvard
Cameron Reitan, MPH, CHES®, currently serves as a Staff Assistant II at the Ragon Institute of Mass General, MIT, and Harvard, contributing to HIV research through support with website management, event planning, scheduling, and expense tracking. Previously, Cameron held the position of Health Policy Researcher at Harvard Medical School and Massachusetts General Hospital, focusing on national vaping policies and conducting qualitative research. Other roles include Research Assistant for the Eliminate Tobacco Missouri Initiative, Personal Care Attendant at Services for Independent Living, Graduate Teaching Assistant at the University of Missouri-Columbia, and WIC Intern at the Columbia/Boone County Department of Public Health and Human Services. Cameron holds a Master's of Public Health in Health Promotion and Policy from the University of Missouri-Columbia and a Bachelor of Health Science in Public Health from the same institution.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.